SULF2 and non-small cell lung carcinoma: In non-small cell lung cancer (NSCLC), miR-527/SULF2 was reported to suppress TGF-β/SMAD signaling pathway and inhibit the epithelial-mesenchymal transition of NSCLC cells [23].